글로벌 중환자 치료 진단 시장 (2023-2030) : 유세포 분석, 혈액학

■ 영문 제목 : Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type (Flow Cytometry, Hematology), By End-use (Operating Room, Emergency Rooms, Intensive Care Units), By Region, And Segment Forecasts, 2023 - 2030

Grand View Research가 발행한 조사보고서이며, 코드는 GRV23NOV086 입니다.■ 상품코드 : GRV23NOV086
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 9월
■ 페이지수 : 85
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 의료
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1인 열람용)USD5,950 ⇒환산₩8,330,000견적의뢰/주문/질문
Multi User (5인 열람용)USD6,950 ⇒환산₩9,730,000견적의뢰/주문/질문
Global/corporate License (기업 열람용)USD8,950 ⇒환산₩12,530,000견적의뢰/구입/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
글로벌 중환자 치료 진단 시장의 성장과 동향
Grand View Research사의 최신 보고서에 따르면, 세계의 중환자 치료 진단 시장 규모는 2030년까지 17. 2억 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균 4. 9%의 성장률을 기록할 것으로 전망됩니다. 업계 성장을 뒷받침하는 주요 요인은 의사와 환자의 이러한 검사에 대한 인식과 인식의 급속한 증가, 노인 인구와 만성 건강 상태의 증가, 원격지에서의 원격 의료 서비스 채택, 기술 발전 등입니다. 분자 진단의 비용 상승과 숙련된 인력 부족은 산업 성장을 저해하는 요인으로 예상되고 있습니다.

중환자 치료 진단 시장을 유형별로 분류하면 일상 및 특수화학, 유세포 분석, 혈액학, 면역단백질, 미생물 및 감염, 응고 검사, 기타로 나뉩니다. 미생물 및 감염 검사 진단 분야는 예측 기간 동안 5. 5% 이상의 CAGR을 기록하며 가장 높은 성장률을 보일 것으로 예상됩니다. 예를 들어, 의료 시스템은 병원균을 식별하기 위해 혈액 배양을 수집하고 처리하는 데 상당한 자원을 소비하고 있습니다.

핵산 증폭 검사 (NAAT)와 같은 중환자 치료 진단 검사는 임상의가 박테리아를 보다 신속하고 정확하게 감지하고 식별할 수 있게 해주며, 적절한 항균제 치료를 가능한 한 빨리 시작하고 피할 수 있는 약물 사용을 중단하고자 하는 임상의에게 지침을 제공합니다. 최종 사용자별 응급실 진단 시장은 수술실, 응급실, 중환자실로 분류됩니다. 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상되는 분야는 응급실입니다.

중환자 치료 진단 시장 보고서 하이라이트

- 아시아 태평양 지역은 예측 기간 동안 CAGR 6. 9%로 가장 빠르게 성장할 것으로 예상됩니다. 고령 인구의 증가, 만성 질환의 유병률 증가, 아시아 태평양 지역의 전문 병원 증가, 농촌 지역의 의료 서비스 및 인프라 개선이 시장 성장을 촉진하는 요인으로 작용할 것으로 보입니다.

- 응급진단 시장에서 유형별로는 면역단백질 진단검사 분야가 가장 큰 점유율을 차지할 것으로 추정됩니다. 신속하고 정확한 예방 의료 서비스에 대한 수요 증가는 시장 성장을 촉진하는 주요 요인 중 하나입니다.

- 최종 사용자별로는 급성기 치료 환자의 약 20%가 중환자실에 입원하는 반면, 약 58%는 응급실에 입원하는 것으로 나타났습니다. 응급실은 예측 기간 동안 가장 높은 CAGR로 급성장할 것으로 예상되며, 응급실 서비스에 대한 환자 수요가 최근 증가하고 있는데, 이는 응급실이 중증 환자의 초기 급성기 진단과 치료를 제공할 수 있기 때문이라고 합니다.
■ 보고서 개요

Chapter 1. 조사 방법 및 범위
Chapter 2. 개요
Chapter 3. 세계의 중환자 치료 진단 시장 변수/동향/범위
Chapter 4. 세계의 중환자 치료 진단 시장 : 유형별 예측 및 동향 분석
Chapter 5. 세계의 중환자 치료 진단 시장 : 최종 용도별 예측 및 동향 분석
Chapter 6. 세계의 중환자 치료 진단 시장 : 지역별 예측 및 동향 분석
Chapter 7. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Critical Care Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Critical Care Diagnostics Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Critical Care Diagnostics: Type Estimates & Trend Analysis
4.1. Critical Care Diagnostics Market: Key Takeaways
4.2. Critical Care Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Routine and Special Chemistry
4.3.1. Routine and special chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Flow Cytometry
4.4.1. Flow cytometry market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Hematology
4.5.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Immunoproteins
4.6.1. Immunoproteins market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Microbial and Infectious Disease
4.7.1. Microbial and infectious disease market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Coagulation Testing
4.8.1. Coagulation testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Others
4.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Critical Care Diagnostics: End Use Estimates & Trend Analysis
5.1. Critical Care Diagnostics Market: Key Takeaways
5.2. Critical Care Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Operation Room
5.3.1. Operation room market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Intensive Care Unit
5.4.1. Intensive care unit market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Emergency Rooms
5.5.1. Emergency rooms market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Critical Care Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Critical Care Diagnostics Market by Region: Key Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. Abbott
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Danaher
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. F. Hoffmann-La Roche Ltd
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. BD
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. EKF Diagnostics
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. bioMérieux, Inc.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Siemens Healthcare Private Limited
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Chembio Diagnostics, Inc.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Bayer AG
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 3 North America critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 4 North America critical care diagnostics market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 6 U.S. critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 7 Canada critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 8 Canada critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 9 Europe critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 10 Europe critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 11 Europe critical care diagnostics market, by region, 2018 - 2030 (USD Million)
Table 12 Germany critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 13 Germany critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 14 UK critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 15 UK critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 16 France critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 17 France critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 18 Italy critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 19 Italy critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 20 Spain critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 21 Spain critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 22 Sweden critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 23 Sweden critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 24 Norway critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 25 Norway critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 26 Denmark critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 27 Denmark critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 29 Asia Pacific critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific critical care diagnostics market, by region, 2018 - 2030 (USD Million)
Table 31 Japan critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 32 Japan critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 33 China critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 34 China critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 35 India critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 36 India critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 37 Australia critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 38 Australia critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 39 Thailand critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 40 Thailand critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 41 South Korea critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 42 South Korea critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 43 Latin America critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 44 Latin America critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 45 Latin America critical care diagnostics market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 47 Brazil critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 48 Mexico critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 49 Mexico critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 50 Argentina critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 51 Argentina critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa critical care diagnostics market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 56 South Africa critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 59 UAE critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 60 UAE critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 61 Kuwait critical care diagnostics market, by type, 2018 - 2030 (USD Million)
Table 62 Kuwait critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
※본 조사보고서 [글로벌 중환자 치료 진단 시장 (2023-2030) : 유세포 분석, 혈액학] (코드 : GRV23NOV086) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [글로벌 중환자 치료 진단 시장 (2023-2030) : 유세포 분석, 혈액학] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!